ModernaMRNA

NASDAQ · USA · Segment 3 of 8 in the Medicine, pharma & life science value chain: Biotech & innovation

Built on mRNA, the technology behind its covid vaccine. The pipeline pushes the same platform into further vaccines and into oncology.

Biotech & innovation: Innovation-driven biotech companies focused on novel treatment modalities.

Key metrics

Market cap

$25.2B

Price

$138.89

Today

−4.3%

Return YTD

+392.1%

Return 1Y

+453.5%

P/E

—

P/S

11.3

P/B

3.7

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

BiotechmRNAVaccines

In the value chain

Products & services

mRNA vaccines
Oncology pipeline
Rare diseases

Competitors

Pfizer/BioNTech
Novavax

Risks

Declining covid revenue
Pipeline still maturing

Supply chain

← Suppliers

Thermo Fisher ScientificTMO

Full supply chain for MRNA →

Same segment: Biotech & innovation

AmgenAMGN Gilead SciencesGILD Vertex PharmaceuticalsVRTX RegeneronREGN BiogenBIIB Alnylam PharmaceuticalsALNY IncyteINCY United TherapeuticsUTHR

Compare MRNA

MRNA vs AMGN MRNA vs GILD MRNA vs VRTX MRNA vs REGN MRNA vs BIIB MRNA vs ALNY

See where Moderna sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →